Literature DB >> 2261743

1,25-Dihydroxyvitamin D-related hypercalcemia in lymphoma: two case reports.

J P Devogelaer1, M Lambert, B Boland, C Godfraind, H Noel, C Nagant de Deuxchaisnes.   

Abstract

We report two patients with non-Hodgkin's lymphoma in whom hypercalcemia and elevated 1,25 dihydroxyvitamin D (1,25-(OH)2D3) levels developed in the absence of any lytic bone lesions. Hypercalcemia responded only transiently to glucocorticoids which were ill tolerated. Intravenous APD administration was needed to circumvene hypercalcemia. Humoral hypercalcemia of malignancy is discussed. Our cases confirm that hypercalcemia associated with elevated 1,25-(OH)2D3 may occur in malignant lymphoma.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2261743     DOI： 10.1007/bf02114405

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  35 in total

1.  Ectopic production of 1,25-dihydroxyvitamin D by B-cell lymphoma as a cause of hypercalcemia.

Authors:  A H Mudde; H van den Berg; P G Boshuis; F C Breedveld; H M Markusse; P M Kluin; O L Bijvoet; S E Papapoulos
Journal:  Cancer       Date:  1987-05-01       Impact factor: 6.860

2.  Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma.

Authors:  N A Breslau; J L McGuire; J E Zerwekh; E P Frenkel; C Y Pak
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

3.  Abnormal vitamin D metabolism in Hodgkin's lymphoma.

Authors:  M Davies; E B Mawer; M E Hayes; G A Lumb
Journal:  Lancet       Date:  1985-05-25       Impact factor: 79.321

4.  Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3.

Authors:  L M Sandler; C G Winearls; L J Fraher; T L Clemens; R Smith; J L O'Riordan
Journal:  Q J Med       Date:  1984

5.  Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride.

Authors:  H I Harinck; O L Bijvoet; A S Plantingh; J J Body; J W Elte; H P Sleeboom; J Wildiers; J P Neijt
Journal:  Am J Med       Date:  1987-06       Impact factor: 4.965

6.  Clinical, hematologic, and pathologic features of leukemic T-cell lymphoma.

Authors:  K Kinoshita; S Kamihira; S Ikeda; Y Yamada; T Muta; T Kitamura; M Ichimaru; T Matsuo
Journal:  Cancer       Date:  1982-10-15       Impact factor: 6.860

7.  Circulating vitamin D metabolites and hypercalcaemia of malignancy.

Authors:  S H Ralston; R A Cowan; A G Robertson; M D Gardner; I T Boyle
Journal:  Acta Endocrinol (Copenh)       Date:  1984-08

8.  Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis.

Authors:  J S Adams; O P Sharma; M A Gacad; F R Singer
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

9.  Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism.

Authors:  P H Stern; J De Olazabal; N H Bell
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

10.  Calcitriol levels in hypercalcemic patients with adult T-cell lymphoma.

Authors:  R C Dodd; C F Winkler; M E Williams; P A Bunn; T K Gray
Journal:  Arch Intern Med       Date:  1986-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.